vidaza
bristol-myers squibb pharma eeig - azacitidín - myelodysplastic syndromes; leukemia, myelomonocytic, chronic; leukemia, myeloid, acute - antineoplastické činidlá - vidaza is indicated for the treatment of adult patients who are not eligible for haematopoietic stem cell transplantation (hsct) with: intermediate 2 and high-risk myelodysplastic syndromes (mds) according to the international prognostic scoring system (ipss),chronic myelomonocytic leukaemia (cmml) with 10 29 % marrow blasts without myeloproliferative disorder,acute myeloid leukaemia (aml) with 20 30 % blasts and multi-lineage dysplasia, according to world health organisation (who) classification. vidaza is indicated for the treatment of adult patients aged 65 years or older who are not eligible for hsct with aml with >30% marrow blasts according to the who classification.
hydrochlorothiazid léČiva
zentiva, k.s., Česká republika - hydrochlorotiazid - 50 - diuretica
femara 2,5 mg
novartis slovakia s.r.o., slovensko - letrozol - 44 - cytostatica
nasonex
n.v. organon, holandsko - mometazón - 69 - otorhinolaryngologica
cisplatina hospira 1 mg/ ml
hospira uk limited - cisplatina - 44 - cytostatica
nebilet hctz 5 mg/12,5 mg
menarini international operations luxembourg s.a., luxembursko - nebivolol a tiazidy - 58 - hypotensiva
nebilet hctz 5 mg/25 mg
menarini international operations luxembourg s.a., luxembursko - nebivolol a tiazidy - 58 - hypotensiva
clarzole
actavis group ptc ehf., island - letrozol - 44 - cytostatica
losartan/hydrochlorotiazid krka 100 mg/25 mg filmom obalené tablety
krka, d.d., novo mesto, slovinsko - losartan a diuretiká - 58 - hypotensiva
losartan/hydrochlorotiazid krka 50 mg/12,5 mg filmom obalené tablety
krka, d.d., novo mesto, slovinsko - losartan a diuretiká - 58 - hypotensiva